AU2001270783B2 - Variolin derivatives as anti-cancer agents - Google Patents

Variolin derivatives as anti-cancer agents Download PDF

Info

Publication number
AU2001270783B2
AU2001270783B2 AU2001270783A AU2001270783A AU2001270783B2 AU 2001270783 B2 AU2001270783 B2 AU 2001270783B2 AU 2001270783 A AU2001270783 A AU 2001270783A AU 2001270783 A AU2001270783 A AU 2001270783A AU 2001270783 B2 AU2001270783 B2 AU 2001270783B2
Authority
AU
Australia
Prior art keywords
group
formula
compound
substituted
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
AU2001270783A
Other languages
English (en)
Other versions
AU2001270783A1 (en
Inventor
Regan James Anderson
Ignacio Manzanares
Jonathan Charles Morris
Modesto Remuinan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0017055A external-priority patent/GB0017055D0/en
Priority claimed from GB0030689A external-priority patent/GB0030689D0/en
Application filed by Pharmamar SA filed Critical Pharmamar SA
Publication of AU2001270783A1 publication Critical patent/AU2001270783A1/en
Application granted granted Critical
Publication of AU2001270783B2 publication Critical patent/AU2001270783B2/en
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
AU2001270783A 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents Revoked AU2001270783B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0017055.5 2000-07-11
GB0017055A GB0017055D0 (en) 2000-07-11 2000-07-11 Synthesis
GB0030689A GB0030689D0 (en) 2000-12-15 2000-12-15 Synthesis
GB0030689.4 2000-12-15
PCT/GB2001/003111 WO2002004447A1 (en) 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2006213946A Division AU2006213946B2 (en) 2000-07-11 2006-09-13 Variolin derivatives as anti-cancer agents

Publications (2)

Publication Number Publication Date
AU2001270783A1 AU2001270783A1 (en) 2002-04-18
AU2001270783B2 true AU2001270783B2 (en) 2006-06-15

Family

ID=26244637

Family Applications (3)

Application Number Title Priority Date Filing Date
AU2001270783A Revoked AU2001270783B2 (en) 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents
AU7078301A Pending AU7078301A (en) 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents
AU2006213946A Ceased AU2006213946B2 (en) 2000-07-11 2006-09-13 Variolin derivatives as anti-cancer agents

Family Applications After (2)

Application Number Title Priority Date Filing Date
AU7078301A Pending AU7078301A (en) 2000-07-11 2001-07-11 Variolin derivatives as anti-cancer agents
AU2006213946A Ceased AU2006213946B2 (en) 2000-07-11 2006-09-13 Variolin derivatives as anti-cancer agents

Country Status (20)

Country Link
US (1) US7320981B2 (enExample)
EP (1) EP1299388B1 (enExample)
JP (1) JP2004502773A (enExample)
KR (1) KR100886161B1 (enExample)
CN (1) CN1324028C (enExample)
AT (1) ATE431349T1 (enExample)
AU (3) AU2001270783B2 (enExample)
BR (1) BR0112413A (enExample)
CA (1) CA2414200C (enExample)
CY (1) CY1109283T1 (enExample)
DE (1) DE60138707D1 (enExample)
DK (1) DK1299388T3 (enExample)
ES (1) ES2327210T3 (enExample)
IL (2) IL153682A0 (enExample)
MX (1) MXPA03000341A (enExample)
NZ (1) NZ523491A (enExample)
PT (1) PT1299388E (enExample)
RU (1) RU2299884C2 (enExample)
SI (1) SI1299388T1 (enExample)
WO (1) WO2002004447A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0019117D0 (en) * 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds
US7902192B2 (en) 2003-05-15 2011-03-08 Arqule, Inc. Inhibitors of P38 and methods of using the same
WO2006010082A1 (en) 2004-07-08 2006-01-26 Arqule, Inc. 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
EP2258704A1 (en) 2004-10-19 2010-12-08 ArQule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
EP1666467A1 (en) * 2004-11-08 2006-06-07 Evotec AG 11Beta-HSD1 Inhibitors
JP5025270B2 (ja) * 2005-01-12 2012-09-12 株式会社クラレ 樹脂組成物及びそれからなるフィルム
BRPI0610828A2 (pt) * 2005-05-16 2010-07-27 Irm Llc compostos e composições como inibidores de proteìna quinase
US11332480B2 (en) 2017-04-27 2022-05-17 Pharma Mar, S.A. Antitumoral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT633886E (pt) * 1992-04-03 2001-03-30 Upjohn Co Aminas biciclicas-heterociclicas farmaceuticamente activas
GB0019117D0 (en) 2000-08-03 2000-09-27 Univ Barcelona Derivatives of variolin B
GB0116966D0 (en) 2001-07-11 2001-09-05 Pharma Mar Sa Anittumoral compounds

Also Published As

Publication number Publication date
RU2299884C2 (ru) 2007-05-27
AU2006213946A1 (en) 2006-10-05
DK1299388T3 (da) 2009-08-31
DE60138707D1 (de) 2009-06-25
CY1109283T1 (el) 2014-07-02
CA2414200A1 (en) 2002-01-17
ES2327210T3 (es) 2009-10-27
ATE431349T1 (de) 2009-05-15
US20050014778A1 (en) 2005-01-20
CN1630658A (zh) 2005-06-22
IL153682A0 (en) 2003-07-06
EP1299388A1 (en) 2003-04-09
WO2002004447A1 (en) 2002-01-17
US7320981B2 (en) 2008-01-22
BR0112413A (pt) 2003-05-27
JP2004502773A (ja) 2004-01-29
KR100886161B1 (ko) 2009-02-27
AU7078301A (en) 2002-01-21
KR20030017581A (ko) 2003-03-03
SI1299388T1 (sl) 2009-12-31
IL153682A (en) 2010-05-31
MXPA03000341A (es) 2004-04-05
CA2414200C (en) 2010-05-04
EP1299388B1 (en) 2009-05-13
NZ523491A (en) 2004-06-25
CN1324028C (zh) 2007-07-04
AU2006213946B2 (en) 2008-01-10
PT1299388E (pt) 2009-08-13

Similar Documents

Publication Publication Date Title
AU2020240382B2 (en) Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective component
CN114981268A (zh) 嘧啶-4(3h)-酮类杂环化合物、其制备方法及其在医药学上的应用
CN117800976A (zh) 一类含氮杂环类化合物、制备方法和用途
AU2006223634A1 (en) Hydroxyalkyl substituted imidazoquinolines
AU2004267052B2 (en) Isothiazoloquinolones and related compounds as anti-infective agents
EP1299388B1 (en) Variolin derivatives as anti-cancer agents
CN120441596A (zh) 嘧啶并杂环类化合物、其药物组合物及其用途
AU2021290208B2 (en) Tricyclic compounds
CN120590414A (zh) 一类含氮杂环类化合物、制备方法和用途
EP4382511A1 (en) Pyrimidine or pyridine derivative, preparation method therefor, and application thereof in pharmacy
AU2001270783A1 (en) Variolin derivatives as anti-cancer agents
CN121100117A (zh) 芳香酰胺类衍生物、其制备方法和其在医药上的应用
AU2002317329B2 (en) Variolin derivatives and their use as antitumor agents
FI73684C (fi) Foerfarande och mellanprodukt foer framstaellning av farmakologiskt verksamma /1,2/-anellerade 1,4-bensodiazepinfoereningar.
US20040019064A1 (en) Pyridopyrimidine derivatives as 5-HT6 antagonists
ZA200300083B (en) Variolin derivatives as anti-cancer agents.
EP0660824A1 (en) 1,2 DIHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3 DIONE AND THEIR USE AS ANTICANCER AGENTS
KR20040048926A (ko) 항암 활성을 갖는 폴리시클릭 화합물
CN118459440A (zh) 四取代芳基化合物制备方法及应用
CA3256000A1 (en) EGFR MACROCYCLIC INHIBITOR, ITS PREPARATION PROCESS AND PHARMACEUTICAL USE
CN119371419A (zh) Pkmyt1激酶抑制剂
CN112694477A (zh) 吡唑并环类化合物，包含其的药物组合物，其制备方法及其用途
CN116803984A (zh) 一种靶向热休克蛋白110kDa（HSP110）抑制剂及其应用
HK40072883A (en) Pyrimidine-4(3h)-ketone heterocyclic compound, preparation method therefor and use thereof in medicine and pharmacology

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MAK Offer to surrender letters patent
MAL Surrender and revocation of letters patent